Previous 10 |
home / stock / gsd:cc / gsd:cc news
Clinical Study demonstrated dual benefit mode of action of Thykamine™ in mild-to-moderate Atopic Dermatitis: Statistically significant effect on Atopic Dermatitis evaluated by measure of IGA, BSA and POEM Statistically beneficial effect on Pruritis (‘...
Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXv: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, a...
Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXv: GSD ; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, ...
Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD ; OTCQB : DVHGF ), a clinical stage botanical pharmaceut...
News, Short Squeeze, Breakout and More Instantly...
Devonian Health Group Inc. Company Name:
GSD:CC Stock Symbol:
TSXVC Market:
Devonian Health Group Inc. Website:
Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), announced today that they will be participating in Renmark Financial Communications Inc.’s (“ Renmark ”) live Virtual Non-Deal Roadshow Series...
Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series in Los Angeles on July 10, 2024...
Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series in Boston on June 26, 2024 to d...